Sparrow Pharmaceuticals
$95.0M
Funding date
Valuation / Funding
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| September 24, 2025 | Later Stage VC (Series B) | $95.0M | N/A | - |
Current Valuation Metrics
Sparrow Pharmaceuticals is currently valued at $139.0M as of September 24, 2025. The company has raised a total of $145.8M in funding across 1 funding round.
Capital Efficiency
With a capital efficiency ratio of 0.95x, Sparrow Pharmaceuticals has achieved a valuation that is 0.95 times the total capital raised.
What is Sparrow Pharmaceuticals Worth in 2026?
Sparrow Pharmaceuticals is a leading private company in the Drug Discovery sector. Track Sparrow Pharmaceuticals's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Sparrow Pharmaceuticals Valuation is Determined
Private company valuations like Sparrow Pharmaceuticals's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.